Literature DB >> 10913311

Molecular recognition of cAMP by an RNA aptamer.

M Koizumi1, R R Breaker.   

Abstract

Two classes of RNA aptamers that bind the second messenger adenosine 3',5'-cyclic monophosphate (cAMP; 1) were isolated from a random-sequence pool using in vitro selection. Class I and class II aptamers are formed by 33- and 31-nucleotide RNAs, respectively, and each is comprised of similar stem-loop and single-stranded structural elements. Class II aptamers, which dominate the final selected RNA population, require divalent cations for complex formation and display a dissociation constant (K(D)) for cAMP of approximately 10 microM. A representative class II aptamer exhibits substantial discrimination against 5'- and 3'-phosphorylated nucleosides such as ATP, 5'-AMP, and 3'-AMP. However, components of cAMP such as adenine and adenosine also are bound, indicating that the adenine moiety is the primary positive determinant of ligand binding. Specificity of cAMP binding appears to be established by hydrogen bonding interactions with the adenine base as well as by steric interactions with groups on the ribose moiety. In addition, the aptamer recognizes 8,5'-O-cycloadenosine (2) but not N(3), 5'-cycloadenosine (3), indicating that this RNA might selectively recognize the anti conformation of the N-glycosidic bond of cAMP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913311     DOI: 10.1021/bi000149n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing.

Authors:  Xianbin Yang; Suzanne E Bassett; Xin Li; Bruce A Luxon; Norbert K Herzog; Robert E Shope; Judy Aronson; Tarl W Prow; James F Leary; Romy Kirby; Andrew D Ellington; David G Gorenstein
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Selection and evolution of NTP-specific aptamers.

Authors:  Laure Weill; Dominique Louis; Bruno Sargueil
Journal:  Nucleic Acids Res       Date:  2004-09-27       Impact factor: 16.971

3.  Artificial tertiary motifs stabilize trans-cleaving hammerhead ribozymes under conditions of submillimolar divalent ions and high temperatures.

Authors:  Vanvimon Saksmerprome; Manami Roychowdhury-Saha; Sumedha Jayasena; Anastasia Khvorova; Donald H Burke
Journal:  RNA       Date:  2004-12       Impact factor: 4.942

Review 4.  Colorimetric biosensors based on DNAzyme-assembled gold nanoparticles.

Authors:  Juewen Liu; Yi Lu
Journal:  J Fluoresc       Date:  2004-07       Impact factor: 2.217

5.  Protein detection via direct enzymatic amplification of short DNA aptamers.

Authors:  Nicholas O Fischer; Theodore M Tarasow; Jeffrey B-H Tok
Journal:  Anal Biochem       Date:  2007-10-01       Impact factor: 3.365

6.  A DNA Aptamer for Cyclic Adenosine Monophosphate that Shows Adaptive Recognition.

Authors:  Suruchi Sharma; Matthew Zajac; Yamuna Krishnan
Journal:  Chembiochem       Date:  2019-08-29       Impact factor: 3.164

7.  Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers.

Authors:  Xianbin Yang; Xin Li; Tarl W Prow; Lisa M Reece; Suzanne E Bassett; Bruce A Luxon; Norbert K Herzog; Judy Aronson; Robert E Shope; James F Leary; David G Gorenstein
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

Review 8.  Nucleic Acid-Based Nanodevices in Biological Imaging.

Authors:  Kasturi Chakraborty; Aneesh T Veetil; Samie R Jaffrey; Yamuna Krishnan
Journal:  Annu Rev Biochem       Date:  2016-06-02       Impact factor: 23.643

Review 9.  The lost language of the RNA World.

Authors:  James W Nelson; Ronald R Breaker
Journal:  Sci Signal       Date:  2017-06-13       Impact factor: 8.192

10.  Aptamers selected for higher-affinity binding are not more specific for the target ligand.

Authors:  James M Carothers; Stephanie C Oestreich; Jack W Szostak
Journal:  J Am Chem Soc       Date:  2006-06-21       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.